Clinical trial
Dupilumab_Metastatic NSCLC
NCT05013450
Study timeline
Study start (actual)2021-09-10Date precision: day
Registry last updated2026-08-31
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Metastatic Non-small Cell Lung Cancerunresolved
Interventions
DupilumabDRUG · verified · RxNorm: dupilumab
AnakinraDRUG · verified · RxNorm: anakinra
Sponsors & collaborators
Thomas Marronlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05013450 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.